Authors:
Visani, G
Milligan, D
Leoni, F
Chang, J
Kelsey, S
Marcus, R
Powles, R
Schey, S
Covelli, A
Isidori, A
Litchman, M
Piccaluga, PP
Mayer, H
Malagola, M
Pfister, C
Citation: G. Visani et al., Combined action of PSC 833 (Valspodar), a novel MDR reversing agent, with mitoxantrone, etoposide and cytarabine in poor-prognosis acute myeloid leukemia, LEUKEMIA, 15(5), 2001, pp. 764-771
Authors:
Silberstein, L
Davies, A
Kelsey, S
Foran, J
Murrell, C
D'Cruz, D
Vinnicombe, S
Norton, A
Cavenagh, J
Citation: L. Silberstein et al., Myositis, polyserositis with a large pericardial effusion and constrictivepericarditis as manifestations of chronic graft-versus-host disease after non-myeloablative peripheral stem cell transplantation and subsequent donorlymphocyte infusion, BONE MAR TR, 27(2), 2001, pp. 231-233
Authors:
Matutes, E
Taylor, GP
Cavenagh, J
Pagliuca, A
Bareford, D
Domingo, A
Hamblin, R
Kelsey, S
Mir, N
Reilly, JT
Citation: E. Matutes et al., Interferon alpha and zidovudine therapy in adult T-cell leukaemia lymphoma: response and outcome in 15 patients, BR J HAEM, 113(3), 2001, pp. 779-784
Authors:
Mesters, RM
Padro, T
Bieker, R
Steins, M
Kreuter, M
Goner, M
Kelsey, S
Scigalla, P
Fiedler, W
Buchner, T
Berdel, WE
Citation: Rm. Mesters et al., Stable remission after administration of the receptor tyrosine kinase inhibitor SU5416 in a patient with refractory acute myeloid leukemia, BLOOD, 98(1), 2001, pp. 241-243
Authors:
Brienza, DM
Karg, PE
Geyer, MJ
Kelsey, S
Trefler, E
Citation: Dm. Brienza et al., The relationship between pressure ulcer incidence and buttock-seat cushioninterface pressure in at-risk elderly wheelchair users, ARCH PHYS M, 82(4), 2001, pp. 529-533
Authors:
Shamash, J
O'Doherty, CA
Oliver, RTD
Kelsey, S
Gupta, RK
Gallagher, CJ
Newland, AC
Lister, TA
Citation: J. Shamash et al., Should high-dose chemotherapy be used to consolidate second or third line treatment in relapsing germ cell tumours?, ACTA ONCOL, 39(7), 2000, pp. 857-863
Authors:
Shamash, J
Oliver, RTD
Gallagher, CJ
Newland, AC
Lister, TA
Kelsey, S
Gupta, RK
O'Doherty, CA
Citation: J. Shamash et al., Pre-induction LDH as a prognostic factor for outcome of high dose chemotherapy (HDCT) for germ cell tumours relapsing or refractory to conventional chemotherapy, BR J CANC, 82(12), 2000, pp. 2022-2023
Authors:
Weber, J
Taylor, G
Chieco-Bianchi, L
de The, G
Weiss, R
Goubau, P
Ebbesen, P
Gessain, A
Ozden, S
Brahic, M
Dokhelar, MC
Guillemain, B
von der Helm, K
Bertazzoni, U
Liso, V
Varnier, O
Saracco, A
Huisman, JG
Bangham, CRM
Catovsky, D
Matutes, E
Dalgleish, A
Lever, AML
Mortimer, P
Tosswill, J
Noone, A
Schulz, T
Vandamme, AM
Carton, H
Willems, L
Kirkhofs, P
Wantzin, P
Christiansen, CB
Hall, W
Mamoun, R
Coste, J
Hermine, O
Gout, O
Dodon, MD
Wattel, E
Desgranges, C
Giraudon, P
Pauli, G
Niewiesk, S
Kucherer, C
Khazaie, K
Grassmann, R
Hatzakis, A
Casoli, C
Wicks, R
Manca, F
Galli, M
Ferrante, P
Boeri, E
Lillo, F
Macchi, B
Avillez, F
Caetano, M
Soriano, V
Illa, I
Horal, P
Andersson, S
Krook, A
Daenke, S
Breuer, J
Kelsey, S
Nightingale, S
Pagliuca, T
Bain, B
Brighty, D
Rudge, P
Ades, T
Cann, AJ
Citation: J. Weber et al., The HTLV European Research Network (HERN) Steering Committee, BIOM HLTH R, 24, 1998, pp. 266-271